M. Lebmeier
Impact in
- Family Practice top 5%
- Medication Adherence and Compliance
- Geriatrics and Gerontology top 10%
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 6
- Economic and Financial Impacts of Cancer 2
-
- Neonatal Respiratory Health Research 4
- Co-authors
- Mark Nuijten (4 shared papers)Dyfrig Hughes (1 shared paper)Maribel Salas (1 shared paper)L. Pericleous (3 shared papers)Dawn Lee (4 shared papers)Anthony J. Hatswell (2 shared papers)Roberta Ara (1 shared paper)Donna Rowen (2 shared papers)
- Journals
- Value in Health (11 papers)Journal of Medical Economics (2 papers)Journal of Innovation and Entrepreneurship (1 paper)PharmacoEconomics (1 paper)Lara D. Veeken (1 paper)
- Partner nations
- United KingdomGermanyNetherlands
In The Last Decade
M. Lebmeier
19 papers receiving 388 citations
Peers
Comparison fields: 5 of 64
- Family Practice 78
- Geriatrics and Gerontology 27
- Rheumatology 80
- Epidemiology 156
- Pulmonary and Respiratory Medicine 121
Countries citing papers authored by M. Lebmeier
This map shows the geographic impact of M. Lebmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lebmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lebmeier more than expected).
Fields of papers citing papers by M. Lebmeier
This network shows the impact of papers produced by M. Lebmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lebmeier. The network helps show where M. Lebmeier may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Lebmeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 96 | |
| 2 | 2007 | 73 | |
| 3 | 2014 | 39 | |
| 4 | 2011 | 38 | |
| 5 | 2010 | 36 | |
| 6 | 2008 | 32 | |
| 7 | 2009 | 21 | |
| 8 | 2012 | 18 | |
| 9 | 2015 | 17 | |
| 10 | 2009 | 16 | |
| 11 | 2020 | 6 | |
| 12 | 2012 | 3 | |
| 13 | 2012 | 3 | |
| 14 | 2023 | 3 | |
| 15 | 2011 | 2 | |
| 16 | 2011 | 2 | |
| 17 | 2012 | 1 | |
| 18 | 2005 | 1 | |
| 19 | 2005 | 1 | |
| 20 | 2012 | 0 |
About M. Lebmeier
M. Lebmeier is a scholar working on Economics and Econometrics, Pulmonary and Respiratory Medicine, Hematology, Surgery and Epidemiology, having authored 21 papers that have together received 408 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Neonatal Respiratory Health Research (4 papers), Respiratory viral infections research (4 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Congenital Diaphragmatic Hernia Studies (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Economic and Financial Impacts of Cancer (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Family Practice (78 citations), Geriatrics and Gerontology (27 citations), Rheumatology (80 citations), Epidemiology (156 citations) and Pulmonary and Respiratory Medicine (121 citations). M. Lebmeier has collaborated with scholars based in United Kingdom, Germany and Netherlands. Frequent co-authors include Mark Nuijten, Dyfrig Hughes, Maribel Salas, L. Pericleous, Dawn Lee, Anthony J. Hatswell, Roberta Ara, Donna Rowen, Robin Christensen and Patricia Guyot. Their work appears in journals such as Value in Health, Journal of Medical Economics, Journal of Innovation and Entrepreneurship, PharmacoEconomics and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.